KeyBanc downgraded Progyny to Sector Weight from Overweight. The firm is becoming more weary of the company’s visibility into its revenues, utilization, and customer behavior, particularly given the roughly 4% miss on revenues in Q1 after providing a muted outlook at the end of February. KeyBanc also mentions that there could be potential further headwinds heading into next year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report
- Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
- Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
- Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
- Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference